Aimei Health Technology closes $69M SPAC IPO, including full over-allotment

Aimei Health Technology Co., Ltd.

Sold 6.9M units at $10/unit; gross proceeds $69M. Each unit = 1 ordinary share + 1 right (entitles 1/5 share).
Underwriters' over-allotment fully exercised for 900k additional units.
Private placement of 332k units to Aimei Investment Ltd raised $3.32M.
Net proceeds of $69.69M placed in trust for public shareholders pending initial business combination.
Blank-check SPAC focused on healthcare innovation; trades on Nasdaq under AFJK, AFJKR, AFJKU.

item 1.01 item 3.02 item 5.03 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Aimei Health Technology Co., Ltd.: Amended and Restated Memorandum and Articles of Association filed in connection with IPO (effective 2023-12-01).

Change: charter amendment
Effective: 2023-12-01

Exact text from the filing

On December 1, 2023, in connection with the IPO, the Company filed its Amended and Restated Memorandum and Articles of Association.

View on SEC.gov

25 governance changes filed in the last 30 days. Browse all governance changes →

Aimei Health Technology Co., Ltd. filing history →

Source: SEC EDGAR

accession 0001493152-23-043918

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.